|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 2517 |
FusionGeneSummary for ARHGEF12_CEP164 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ARHGEF12_CEP164 | Fusion gene ID: 2517 | Hgene | Tgene | Gene symbol | ARHGEF12 | CEP164 | Gene ID | 23365 | 22897 |
| Gene name | Rho guanine nucleotide exchange factor 12 | centrosomal protein 164 | |
| Synonyms | LARG|PRO2792 | NPHP15 | |
| Cytomap | 11q23.3 | 11q23.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | rho guanine nucleotide exchange factor 12Rho guanine nucleotide exchange factor (GEF) 12leukemia-associated RhoGEFleukemia-associated rho guanine nucleotide exchange factor | centrosomal protein of 164 kDacentrosomal protein 164kDa | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q9NZN5 | Q9UPV0 | |
| Ensembl transtripts involved in fusion gene | ENST00000397843, ENST00000356641, ENST00000532993, | ENST00000278935, ENST00000533706, | |
| Fusion gene scores | * DoF score | 11 X 8 X 8=704 | 3 X 3 X 3=27 |
| # samples | 14 | 3 | |
| ** MAII score | log2(14/704*10)=-2.33014860169233 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: ARHGEF12 [Title/Abstract] AND CEP164 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | ARHGEF12 | GO:0007186 | G-protein coupled receptor signaling pathway | 15755723 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | SARC | TCGA-QQ-A5VA-01A | ARHGEF12 | chr11 | 120207984 | + | CEP164 | chr11 | 117209282 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000397843 | ENST00000278935 | ARHGEF12 | chr11 | 120207984 | + | CEP164 | chr11 | 117209282 | + |
| 5CDS-intron | ENST00000397843 | ENST00000533706 | ARHGEF12 | chr11 | 120207984 | + | CEP164 | chr11 | 117209282 | + |
| 5CDS-5UTR | ENST00000356641 | ENST00000278935 | ARHGEF12 | chr11 | 120207984 | + | CEP164 | chr11 | 117209282 | + |
| 5CDS-intron | ENST00000356641 | ENST00000533706 | ARHGEF12 | chr11 | 120207984 | + | CEP164 | chr11 | 117209282 | + |
| intron-5UTR | ENST00000532993 | ENST00000278935 | ARHGEF12 | chr11 | 120207984 | + | CEP164 | chr11 | 117209282 | + |
| intron-intron | ENST00000532993 | ENST00000533706 | ARHGEF12 | chr11 | 120207984 | + | CEP164 | chr11 | 117209282 | + |
Top |
FusionProtFeatures for ARHGEF12_CEP164 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ARHGEF12 | CEP164 |
| May play a role in the regulation of RhoA GTPase byguanine nucleotide-binding alpha-12 (GNA12) and alpha-13 (GNA13).Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPaseand may act as GTPase-activating protein (GAP) for GNA12 andGNA13. {ECO:0000269|PubMed:11094164}. | Plays a role in microtubule organization and/ormaintenance for the formation of primary cilia (PC), amicrotubule-based structure that protrudes from the surface ofepithelial cells. Plays a critical role in G2/M checkpoint andnuclear divisions. A key player in the DNA damage-activatedATR/ATM signaling cascade since it is required for the properphosphorylation of H2AX, RPA, CHEK2 and CHEK1. Plays a criticalrole in chromosome segregation, acting as a mediator required forthe maintenance of genomic stability through modulation of MDC1,RPA and CHEK1. {ECO:0000269|PubMed:17954613,ECO:0000269|PubMed:18283122, ECO:0000269|PubMed:23348840}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ARHGEF12_CEP164 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ARHGEF12_CEP164 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| ARHGEF12 | ARHGEF12, RHOA, IGF1R, PLXNB2, PLXNB1, GNA12, GNA13, TEC, CUL3, ARRB2, CYLD, KLHL20, CCDC183, SLC25A41, TRMT61A, VAPB, NTRK1, CLK1, NIPSNAP1, SMC3, VAPA, GAN, MYO6, CDH1, RHOC, TRIM25 | CEP164 | ATR, ATRIP, ELAVL1, UBC, CCDC92, TTBK2, NPHP3, NPHP1, INVS, NPHP4, DVL3, MAPK14, SHMT2, MOV10, LIPH, OFD1, PCM1, CEP128, BTF3, C1orf131, CAPN1, CEBPZ, CTSB, DDX24, DDX47, DNAJB6, EBNA1BP2, GLUD2, IDH3B, LONP1, MTPN, NMD3, NSUN2, PDS5B, PEF1, PPM1F, RBFOX2, RFC2, RPP38, SENP3, SRSF2, SSR3, STX8, WDR3, YY1, AATF, C17orf85, CSRP2, DBT, DDX23, DDX56, ECH1, GPX1, NKRF, NOL11, NUP205, NVL, PDCD11, RPF2, SRSF10, SSRP1, SUPT16H, TBL3, TIMM23B, TOP2B, TRA2B, USP36, VN1R5, ZNF326, CEP89, NIN, NHP2L1, RNASEH2B, LDHD, CDC16, NCAPH2, RFWD2, FAM19A3, RALBP1, THSD4, CRYL1, CELA1, SYCE3, BBS7 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ARHGEF12_CEP164 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ARHGEF12_CEP164 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | ARHGEF12 | C0043094 | Weight Gain | 1 | CTD_human |
| Tgene | CEP164 | C3541853 | NEPHRONOPHTHISIS 15 | 1 | UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|